Literatuuroverzicht tot 28-05-2020

1. Hirsutism, Amphetamines, COVID-19 Viral Shedding, Hand-Foot-and-Mouth Disease. American family

physician. 2020;101(10):589.

2. Recommendations by the SEPD and AEG, both in general and on the operation of gastrointestinal

endoscopy and gastroenterology units, concerning the current SARS-CoV-2 pandemic (March, 18). Revista

espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

2020;112(4):319-22.

3. The transmissibility of novel Coronavirus in the early stages of the 2019-20 outbreak in Wuhan:

Exploring initial point-source exposure sizes and durations using scenario analysis. Abbott S, Hellewell J,

Munday J, Funk S. Wellcome open research. 2020;5:17. http://dx.doi.org/10.12688/wellcomeopenres.15718.1.

eCollection 2020.

4. Effect of cat litters on feline coronavirus infection of cell culture and cats. Addie D, Houe L, Maitland K,

Passantino G, Decaro N. Journal of Feline Medicine and Surgery. 2020;22(4):350-7.

5. Oral Mutian®X stopped faecal feline coronavirus shedding by naturally infected cats. Addie DD,

Curran S, Bellini F, Crowe B, Sheehan E, Ukrainchuk L, et al. Research in Veterinary Science. 2020;130:222-9.

6. First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for

the wastewater surveillance of COVID-19 in the community. Ahmed W, Angel N, Edson J, Bibby K, Bivins A,

O'Brien JW, et al. Science of the Total Environment. 2020;728.

7. Understanding dynamics of pandemics. Akin L, Gözel MG. Turkish Journal of Medical Sciences.

2020;50:515-9.

8. SAT-028 ACUTE KIDNEY INJURY ASSOCIATED WITH MIDDLE EAST RESPIRATORY SYNDROME

CORONAVIRUS (MERS-CoV) INFECTION. Alkindi F, Boobes Y, Chandrasekhar Nair S, Hashmey R. Kidney

International Reports. 2020;5(3):S13.

9. 2020 - the year of the nurse and midwife: a call for action to scale up and strengthen the nursing and

midwifery workforce in the Eastern Mediterranean Region. Al-Mandhari A, Gedik FG, Mataria A, Oweis A, Hajjeh R.

Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah

li-sharq al-mutawassit. 2020;26(4):370-1. http://dx.doi.org/10.26719/2020.26.4.370.

10. Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we

learned? Al-Tawfiq JA. Travel Medicine and Infectious Disease. 2020;34.

11. Emergency Colorectal Surgery in a COVID-19 Pandemic Epicenter. Angelos G, Dockter AG, Gachabayov

M, Latifi R, Bergamaschi R. Surgical technology international. 2020;36.

12. Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A

Multicenter Observational Study. Arabi YM, Shalhoub S, Mandourah Y, Al-Hameed F, Al-Omari A, Al Qasim E, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020;70(9):1837-44.

13. Lung involvement found on chest CT scan in a pre-symptomatic person with SARS-CoV-2 infection: A

case report. Asadollahi-Amin A, Hasibi M, Ghadimi F, Rezaei H, SeyedAlinaghi S. Tropical Medicine and Infectious

Disease. 2020;5(2).

14. COVID-19: Yet another coronavirus challenge in transplantation. Aslam S, Mehra MR. Journal of Heart

and Lung Transplantation. 2020;39(5):408-9.

15. SARS-CoV-2 shedding and infectivity. Atkinson B, Petersen E. The Lancet. 2020;395(10233):1339-40.

16. Management of patients with COPD during the COVID-19 pandemic. Attaway A. Cleveland Clinic journal

of medicine. 2020.

17. Co-infection with SARS-CoV-2 and influenza A virus. Azekawa S, Namkoong H, Mitamura K, Kawaoka Y,

Saito F. IDCases. 2020;20.

18. Case series of coronavirus (SARS-CoV-2) in a military recruit school: clinical, sanitary and logistical

implications. Baettig SJ, Parini A, Cardona I, Morand GB. BMJ military health. 2020.

http://dx.doi.org/10.1136/bmjmilitary-2020-001482.

19. Biopsychopharmacosocial approach to assess impact of social distancing and isolation on mental

health in older adults. Baker E, Clark LL. British journal of community nursing. 2020;25(5):231-8.

http://dx.doi.org/10.12968/bjcn.2020.25.5.231.

20. COVID-19: Emerging protective measures. Balachandar V, Mahalaxmi I, Kaavya J, Vivekanandhan G,

Ajithkumar S, Arul N, et al. European review for medical and pharmacological sciences. 2020;24(6):3422-5.

21. Coronavirus Disease 2019 (COVID-19) in Children - What We Know So Far and What We Do Not.

Balasubramanian S, Rao NM, Goenka A, Roderick M, Ramanan AV. Indian Pediatr. 2020;57(5):435-42.

http://dx.doi.org/10.1007/s13312-020-1819-5. Epub 2020 Apr 9.

22. Reinfection could not occur in SARS-CoV-2 infected rhesus macaques. Bao L, Deng W, Gao H, Xiao C, Liu

J, Xue J, et al. bioRxiv. 2020:2020.03.13.990226.

23. Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2)

through a drug-target interaction deep learning model. Beck BR, Shin B, Choi Y, Park S, Kang K. Computational

and Structural Biotechnology Journal. 2020;18:784-90.

24. COVID-19: towards controlling of a pandemic. Bedford J, Enria D, Giesecke J, Heymann DL, Ihekweazu C,

Kobinger G, et al. The Lancet. 2020;395(10229):1015-8.

25. Covid-19: Testing times. Beeching NJ, Fletcher TE, Beadsworth MBJ. The BMJ. 2020;369.

26. Frequent Hand Washing for COVID-19 Prevention Can Cause Hand Dermatitis: Management Tips. Beiu

C, Mihai M, Popa L, Cima L, Popescu MN. Cureus. 2020;12(4):e7506. http://dx.doi.org/10.7759/cureus.7506.

27. The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic

activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases? Belen-Apak FB,

Sarialioglu F. Medical Hypotheses. 2020;142.

28. 4 Cases: HIV and SARS-CoV-2 Co-infection in patients from Long Island, New York. Benkovic S, Kim M,

Sin E. Journal of medical virology. 2020.

29. COVID-19 and MS disease-modifying therapies. Berger JR, Brandstadter R, Bar-Or A. Neurology(R)

neuroimmunology & neuroinflammation. 2020;7(4).

30. Covid-19 in Critically Ill Patients in the Seattle Region - Case Series. Bhatraju PK, Ghassemieh BJ, Nichols

M, Kim R, Jerome KR, Nalla AK, et al. The New England journal of medicine. 2020;382(21):2012-22.

http://dx.doi.org/10.1056/NEJMoa2004500. Epub 2020 Mar 30.

31. Ginkgolic acid inhibits fusion of enveloped viruses. Borenstein R, Hanson BA, Markosyan RM, Gallo ES,

Narasipura SD, Bhutta M, et al. Sci Rep. 2020;10(1):4746. http://dx.doi.org/10.1038/s41598-020-61700-0.

32. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two

weeks of confirmed presentations to an affiliated pair of New York City hospitals. Breslin N, Baptiste C,

Gyamfi-Bannerman C, Miller R, Martinez R, Bernstein K, et al. American Journal of Obstetrics and Gynecology MFM.

2020.

33. COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of

confirmed presentations to an affiliated pair of New York City hospitals. Breslin N, Baptiste C, Gyamfi-Bannerman

C, Miller R, Martinez R, Bernstein K, et al. American journal of obstetrics & gynecology MFM. 2020:100118.

http://dx.doi.org/10.1016/j.ajogmf.2020.100118.

34. (Indoor) isolation, stress and physical inactivity: vicious circles accelerated by Covid-19? Burtscher J,

Burtscher M, Millet GP. Scandinavian journal of medicine & science in sports. 2020.

35. A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features.

Cai J, Xu J, Lin D, Yang Z, Xu L, Qu Z, et al. Clinical infectious diseases : an official publication of the Infectious Diseases

Society of America. 2020.

36. COVID-19 in a designated infectious diseases hospital outside Hubei Province, China. Cai Q, Huang D,

Ou P, Yu H, Zhu Z, Xia Z, et al. Allergy: European Journal of Allergy and Clinical Immunology. 2020.

37. SARS-CoV-2 infection diagnosed only by cell culture isolation before the local outbreak in an Italian

seven-week-old suckling baby. Calderaro A, Arcangeletti MC, De Conto F, Buttrini M, Montagna P, Montecchini S, et

al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious

Diseases. 2020. http://dx.doi.org/10.1016/j.ijid.2020.05.035.

38. Active implications for dermatologists in "SARS-CoV-2 era": Personal experience and review of

literature. Campanati A, Brisigotti V, Diotallevi F, D'Agostino GM, Paolinelli M, Radi G, et al. Journal of the European

Academy of Dermatology and Venereology : JEADV. 2020.

39. Transmission risk of SARS-CoV-2 to healthcare workers -observational results of a primary care

hospital contact tracing. Canova V, Lederer Schläpfer H, Piso RJ, Droll A, Fenner L, Hoffmann T, et al. Swiss Med

Wkly. 2020;150:w20257. http://dx.doi.org/10.4414/smw.2020.20257. eCollection 2020 Apr 20.

40. Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan,

China. Cao J, Tu WJ, Cheng W, Yu L, Liu YK, Hu X, et al. Clinical infectious diseases : an official publication of the

Infectious Diseases Society of America. 2020.

41. Expert recommendations for the care of newborns of mothers with COVID-19. Carvalho WB, Gibelli M,

Krebs VLJ, Calil V, Johnston C. Clinics (Sao Paulo, Brazil). 2020;75:e1932. http://dx.doi.org/10.6061/clinics/2020/e1932.

Epub 2020 May 15.

42. Interpersonally-based fears during the covid-19 pandemic: Reflections on the fear of missing out and

the fear of not mattering constructs. Casale S, Flett GL. Clinical Neuropsychiatry. 2020;17(2):88-93.

43. COVID-19 pandemic - A focused review for clinicians. Cevik M, Bamford C, Ho A. Clinical microbiology

and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020.

44. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in

golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Chan JFW, Zhang AJ,

Yuan S, Poon VKM, Chan CCS, Lee ACY, et al. Clinical infectious diseases : an official publication of the Infectious

Diseases Society of America. 2020.

45. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection. Chang,

Mo G, Yuan X, Tao Y, Peng X, Wang F, et al. American journal of respiratory and critical care medicine. 2020.

46. Coronavirus Disease 2019: Coronaviruses and Blood Safety. Chang L, Yan Y, Wang L. Transfusion

Medicine Reviews. 2020.

47. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019

(COVID-19). Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A, et al. Canadian Journal of

Ophthalmology. 2020.

48. Clinical progression of patients with COVID-19 in Shanghai, China. Chen J, Qi T, Liu L, Ling Y, Qian Z, Li T,

et al. Journal of Infection. 2020;80(5):e1-e6.

49. [Pregnancy with new coronavirus infection: clinical characteristics and placental pathological analysis

of three cases]. Chen S, Huang B, Luo DJ, Li X, Yang F, Zhao Y, et al. Zhonghua bing li xue za zhi = Chinese journal of

pathology. 2020;49(5):418-23. http://dx.doi.org/10.3760/cma.j.cn112151-20200225-00138.

50. Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with

COVID-19 in Guangzhou, China: a retrospective cohort study. Chen X, Zhang Y, Zhu B, Zeng J, Hong W, He X, et al.

medRxiv. 2020:2020.04.09.20058941.

51. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. Chen Y, Chen L, Deng Q, Zhang G,

Wu K, Ni L, et al. Journal of Medical Virology. 2020.

52. SARS-CoV-2: virus dynamics and host response. Chen Y, Li L. The Lancet Infectious Diseases.

2020;20(5):515-6.

53. Infants Born to Mothers With a New Coronavirus (COVID-19). Chen Y, Peng H, Wang L, Zhao Y, Zeng L,

Gao H, et al. Frontiers in pediatrics. 2020;8.

54. COVID-19 with rheumatic diseases: a report of 5 cases. Cheng C, Li C, Zhao T, Yue J, Yang F, Yan Y, et al.

Clinical rheumatology. 2020.

55. Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild

pneumonia in Taiwan. Cheng CY, Lee YL, Chen CP, Lin YC, Liu CE, Liao CH, et al. Journal of Microbiology,

Immunology and Infection. 2020.

56. Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative

Review. Cheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, et al. Annals of internal medicine.

2020.

57. First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan. Cheng SC, Chang YC, Fan

Chiang YL, Chien YC, Cheng M, Yang CH, et al. Journal of the Formosan Medical Association. 2020;119(3):747-51.

58. Dynamic interventions to control COVID-19 pandemic: a multivariate prediction modelling study

comparing 16 worldwide countries. Chowdhury R, Heng K, Shawon MSR, Goh G, Okonofua D, Ochoa-Rosales C, et

al. European journal of epidemiology. 2020:1-11. http://dx.doi.org/10.1007/s10654-020-00649-w.

59. More data are required for incubation period, infectivity, and quarantine duration for COVID-19.

Cimolai N. Travel Med Infect Dis. 2020:101713. http://dx.doi.org/10.1016/j.tmaid.2020.101713.

60. SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged

Viral RNA Detection. Colavita F, Lapa D, Carletti F, Lalle E, Bordi L, Marsella P, et al. Annals of internal medicine. 2020.

61. Impact of the COVID-19 epidemic on census, organization and activity of a large urban Emergency

Department. Comelli I, Scioscioli F, Cervellin G. Acta bio-medica : Atenei Parmensis. 2020;91(2):45-9.

62. Airborne route and bad use of ventilation systems as non-negligible factors in SARS-CoV-2

transmission. Correia G, Rodrigues L, Gameiro da Silva M, Gonçalves T. Medical Hypotheses. 2020;141.

63. Epidemiological research priorities for public health control of the ongoing global novel coronavirus

(2019-nCoV) outbreak. Cowling BJ, Leung GM. Eurosurveillance. 2020;25(6).

64. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in

patients with diabetes during COVID-19 pandemic. Cure E, Cumhur Cure M. Diabetes and Metabolic Syndrome:

Clinical Research and Reviews. 2020;14(4):349-50.

65. Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis. Cure E, Cumhur

Cure M. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):405-6.

66. Profile of a killer: the complex biology powering the coronavirus pandemic. Cyranoski D. Nature.

2020;581(7806):22-6.

67. An investigation into respiratory tract viruses in children with acute lower respiratory tract infection

or wheezing. Dabaniyasti D, Eksi F, Keskin Ö, Özkars MY, Karsligil T, Balci I. Minerva Pediatrica. 2020;72(1):45-54.

68. Diarrhea during COVID-19 infection: pathogenesis, epidemiology, prevention and management.

D'Amico F, Baumgart DC, Danese S, Peyrin-Biroulet L. Clinical gastroenterology and hepatology : the official clinical

practice journal of the American Gastroenterological Association. 2020.

69. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Dashraath P, Wong JLJ, Lim MXK, Lim

LM, Li S, Biswas A, et al. American Journal of Obstetrics and Gynecology. 2020.

70. Endoscopic Skull Base and Transoral Surgery During the COVID-19 Pandemic: Minimizing Droplet

Spread with a Negative-Pressure Otolaryngology Viral Isolation Drape (NOVID). David AP, Jiam NT, Reither JM,

Gurrola JG, 2nd, Aghi M, El-Sayed IH. Head & neck. 2020. http://dx.doi.org/10.1002/hed.26239.

71. Mutated COVID-19 may foretell a great risk for mankind in the future. Dawood AA. New Microbes and

New Infections. 2020;35.

72. Head and neck oncology during the COVID-19 pandemic: Reconsidering traditional treatment

paradigms in light of new surgical and other multilevel risks. Day AT, Sher DJ, Lee RC, Truelson JM, Myers LL,

Sumer BD, et al. Oral Oncol. 2020;105:104684. http://dx.doi.org/10.1016/j.oraloncology.2020.104684. Epub 2020 Apr

6.

73. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of

MERS-CoV infection. de Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, et al. Proceedings of the

National Academy of Sciences of the United States of America. 2020;117(12):6771-6.

74. COVID-19 from veterinary medicine and one health perspectives: What animal coronaviruses have

taught us. Decaro N, Martella V, Saif LJ, Buonavoglia C. Research in Veterinary Science. 2020;131:21-3.

75. Timing of Tracheotomy in Intubated Patients With COVID-19. Delides A, Maragoudakis P, Nikolopoulos

T. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck

Surgery. 2020:194599820930668.

76. The global battle against SARS-CoV-2 and COVID-19. Deng CX. International journal of biological

sciences. 2020;16(10):1676-7.

77. SARS-COV-2 was already spreading in France in late December 2019. Deslandes A, Berti V,

Tandjaoui-Lambotte Y, Alloui C, Carbonnelle E, Zahar JR, et al. International journal of antimicrobial agents.

2020:106006.

78. Strategies for daily operating room management of ambulatory surgery centers following resolution

of the acute phase of the COVID-19 pandemic. Dexter F, Elhakim M, Loftus RW, Seering MS, Epstein RH. J Clin

Anesth. 2020;64:109854. http://dx.doi.org/10.1016/j.jclinane.2020.109854.

79. Pathophysiology of COVID-19: Why Children Fare Better than Adults? Dhochak N, Singhal T, Kabra SK,

Lodha R. Indian Journal of Pediatrics. 2020.

80. Coronavirus pandemic and Colorectal surgery: practical advice based on the Italian experience. Di

Saverio S, Pata F, Gallo G, Carrano F, Scorza A, Sileri P, et al. Colorectal disease : the official journal of the Association

of Coloproctology of Great Britain and Ireland. 2020.

81. 2019 Novel coronavirus (CoviD-19) pandemic: Built environment considerations to reduce

transmission. Dietz L, Horve PF, Coil DA, Fretz M, Eisen JA, van Den Wymelenberg K. mSystems. 2020;5(2).

82. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and

influenza virus in Wuhan, China. Ding Q, Lu P, Fan Y, Xia Y, Liu M. Journal of Medical Virology. 2020.

83. Covid-19 Outbreak Progression in Italian Regions: Approaching the Peak by the End of March in

Northern Italy and First Week of April in Southern Italy. Distante C, Piscitelli P, Miani A. International journal of

environmental research and public health. 2020;17(9). http://dx.doi.org/10.3390/ijerph17093025.

84. The role of imaging in the detection and management of COVID-19: a review. Dong D, Tang Z, Wang S,

Hui H, Gong L, Lu Y, et al. IEEE Reviews in Biomedical Engineering. 2020.

85. Mathematical Modeling of Interaction between Innate and Adaptive Immune Responses in COVID-19

and Implications for Viral Pathogenesis. Du SQ, Yuan W. Journal of Medical Virology. 2020.

86. Epidemic update of COVID-19 in Hubei Province compared with other regions in China. Du W, Han S,

Li Q, Zhang Z. International journal of infectious diseases : IJID : official publication of the International Society for

Infectious Diseases. 2020.

87. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Duan K, Liu B, Li C, Zhang H,

Yu T, Qu J, et al. Proceedings of the National Academy of Sciences of the United States of America.

2020;117(17):9490-6.

88. Neonatal Coronavirus 2019 (COVID-19) Infection: A Case Report and Review of Literature. Dumpa V,

Kamity R, Vinci AN, Noyola E, Noor A. Cureus. 2020;12(5):e8165. http://dx.doi.org/10.7759/cureus.8165.

89. COVID-19 – the role of mass gatherings. Ebrahim SH, Memish ZA. Travel Medicine and Infectious Disease.

2020;34.

90. Inactivation of three emerging viruses – severe acute respiratory syndrome coronavirus,

Crimean–Congo haemorrhagic fever virus and Nipah virus – in platelet concentrates by ultraviolet C light and

in plasma by methylene blue plus visible light. Eickmann M, Gravemann U, Handke W, Tolksdorf F, Reichenberg S,

Müller TH, et al. Vox Sanguinis. 2020;115(3):146-51.

91. To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the

COVID-19 pandemic. Eikenberry SE, Mancuso M, Iboi E, Phan T, Eikenberry K, Kuang Y, et al. Infectious Disease

Modelling. 2020;5:293-308.

92. Prolonged grief disorder following the Coronavirus (COVID-19) pandemic. Eisma MC, Boelen PA,

Lenferink LIM. Psychiatry Research. 2020;288.

93. Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent

RNA polymerase (RdRp): A molecular docking study. Elfiky AA. Life sciences. 2020;253.

94. Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19. Fang X, Mei

Q, Yang T, Li L, Wang Y, Tong F, et al. Journal of Infection. 2020.

95. Comparisons of viral shedding time of SARS-CoV-2 of different samples in ICU and non-ICU patients.

Fang Z, Zhang Y, Hang C, Ai J, Li S, Zhang W. Journal of Infection. 2020.

96. A field indoor air measurement of SARS-CoV-2 in the patient rooms of the largest hospital in Iran.

Faridi S, Niazi S, Sadeghi K, Naddafi K, Yavarian J, Shamsipour M, et al. Science of the Total Environment. 2020;725.

97. Protection and disinfection policies against SARS-CoV-2 (COVID-19). Fathizadeh H, Maroufi P,

Momen-Heravi M, Dao S, Köse Ş, Ganbarov K, et al. Le infezioni in medicina. 2020;28(2):185-91.

98. A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with

Gastroenteritis and Developing Severe Pulmonary Disease. Ferrey AJ, Choi G, Hanna RM, Chang Y, Tantisattamo E,

Ivaturi K, et al. American Journal of Nephrology. 2020.

99. The importance of repeat testing in detecting coronavirus disease 2019 (COVID-19) in a coronary

artery bypass grafting patient. Fisher B, Seese L, Sultan I, Kilic A. Journal of Cardiac Surgery. 2020.

100. Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19

Pandemic: AASLD Expert Panel Consensus Statement. Fix OK, Hameed B, Fontana RJ, Kwok RM, McGuire BM,

Mulligan DC, et al. Hepatology (Baltimore, Md). 2020.

101. Impact Factors of Viral Shedding in Patients with SARS-CoV-2 Infected Pneumonia. Fu Y, Han P, Zhu R,

Bai T, Yi J, Zhao X, et al. 2020.

102. Risk Factors for Viral RNA Shedding in COVID-19 Patients. Fu Y, Han P, Zhu R, Bai T, Yi J, Zhao X, et al.

The European respiratory journal. 2020.

103. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence:

lessons from other pathogenic viruses. Fung SY, Yuen KS, Ye ZW, Chan CP, Jin DY. Emerging Microbes and

Infections. 2020;9(1):558-70.

104. The time for universal masking of the public for coronavirus disease 2019 is now. Gandhi M, Havlir D.

Open Forum Infectious Diseases. 2020;7(4).

105. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19

associated pneumonia in clinical studies. Gao J, Tian Z, Yang X. Bioscience trends. 2020;14(1):72-3.

106. Characterization, pathogenicity and protective efficacy of a cell culture-derived porcine

deltacoronavirus. Gao X, Zhao D, Zhou P, Zhang L, Li M, Li W, et al. Virus Research. 2020;282.

107. A cluster of the Corona Virus Disease 2019 caused by incubation period transmission in Wuxi, China.

Gao Y, Shi C, Chen Y, Shi P, Liu J, Xiao Y, et al. Journal of Infection. 2020.

108. Optimizing hydroxychloroquine dosing for patients with COVID-19: An integrative modeling

approach for effective drug repurposing. Garcia-Cremades M, Solans BP, Hughes E, Ernest JP, Wallender E, Aweeka

F, et al. Clinical Pharmacology and Therapeutics. 2020.

109. Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80

COVID-19 patients with at least a six-day follow up: A pilot observational study. Gautret P, Lagier JC, Parola P,

Hoang VT, Meddeb L, Sevestre J, et al. Travel Medicine and Infectious Disease. 2020;34.

110. Are Type 1 Interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?

Gemcioglu E, Davutoglu M, Ozdemir EE, Erden A. Multiple sclerosis and related disorders. 2020:102196.

111. Sinonasal pathophysiology of SARS-CoV-2 and COVID-19: A systematic review of the current

evidence. Gengler I, Wang JC, Speth MM, Sedaghat AR. Laryngoscope Investigative Otolaryngology. 2020.

112. Scientists are sprinting to outpace the novel coronavirus. Ghebreyesus TA, Swaminathan S. The Lancet.

2020;395(10226):762-4.

113. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2

(SARS-CoV-2) in the USA. Ghinai I, McPherson TD, Hunter JC, Kirking HL, Christiansen D, Joshi K, et al. The Lancet.

2020;395(10230):1137-44.

114. Drug Development and Medicinal Chemistry Efforts Toward SARS-Coronavirus and Covid-19

Therapeutics. Ghosh AK, Brindisi M, Shahabi D, Chapman ME, Mesecar AD. ChemMedChem. 2020.

115. Research on COVID-19 virus spreading statistics based on the examples of the cases from different

counties. Gondauri D, Mikautadze E, Batiashvili M. Electronic Journal of General Medicine. 2020;17(4).

116. The double burden of disease of COVID-19 in cardiovascular patients: overlapping conditions could

lead to overlapping treatments. Gonzalez-Jaramillo N, Low N, Franco OH. European journal of epidemiology.

2020;35(4):335-7.

117. Novel findings from a beta coronavirus outbreak on an American Miniature Horse breeding farm in

upstate New York. Goodrich EL, Mittel LD, Glaser A, Ness SL, Radcliffe RM, Divers TJ. Equine Veterinary Education.

2020;32(3):150-4.

118. What do surgeons need to know about the digestive disorders and paraclinical abnormalities induced

by COVID-19? Gornet JM, Tran Minh ML, Leleu F, Hassid D. Journal of visceral surgery. 2020.

http://dx.doi.org/10.1016/j.jviscsurg.2020.04.017.

119. Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies

are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses. Gorse GJ,

Donovan MM, Patel GB. Journal of Medical Virology. 2020;92(5):512-7.

120. Baseline Characteristics and Outcomes of 1591 Patients Infected with SARS-CoV-2 Admitted to ICUs

of the Lombardy Region, Italy. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. JAMA -

Journal of the American Medical Association. 2020;323(16):1574-81.

121. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19). Guo L, Ren L,

Yang S, Xiao M, Chang D, Yang F, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa310.

122. Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review. Gupta S, Parker J, Smits S,

Underwood J, Dolwani S. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain

and Ireland. 2020.

123. SARS-COV-2 infection (coronavirus disease 2019) for the gastrointestinal consultant. Hajifathalian K,

Mahadev S, Schwartz RE, Shah S, Sampath K, Schnoll-Sussman F, et al. World Journal of Gastroenterology.

2020;26(14):1546-53.

124. Sequential analysis of viral load in a neonate and her mother infected with SARS-CoV-2. Han MS,

Seong MW, Heo EY, Park JH, Kim N, Shin S, et al. Clinical infectious diseases : an official publication of the Infectious

Diseases Society of America. 2020.

125. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster. Han Y, Jiang

M, Xia D, He L, Lv X, Liao X, et al. Clinical immunology (Orlando, Fla). 2020;214:108413.

http://dx.doi.org/10.1016/j.clim.2020.108413. Epub 2020 Apr 8.

126. Prolonged viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma

donors. Hartman WR, Hess AS, Connor J. medRxiv. 2020:2020.05.07.20090621.

127. The relative transmissibility of asymptomatic COVID-19 infections among close contacts. He D, Zhao S,

Lin Q, Zhuang Z, Cao P, Wang MH, et al. International Journal of Infectious Diseases. 2020;94:145-7.

128. Temporal dynamics in viral shedding and transmissibility of COVID-19. He X, Lau EHY, Wu P, Deng X,

Wang J, Hao X, et al. Nature Medicine. 2020;26(5):672-5.

129. Public health might be endangered by possible prolonged discharge of SARS-CoV-2 in stool. He Y,

Wang Z, Li F, Shi Y. Journal of Infection. 2020;80(5):e18-e9.

130. COVID-19 – Considerations for the paediatric rheumatologist. Hedrich CM. Clinical Immunology.

2020;214.

131. Transmission of COVID-19 to Health Care Personnel During Exposures to a Hospitalized Patient -

Solano County, California, February 2020. Heinzerling A, Stuckey MJ, Scheuer T, Xu K, Perkins KM, Resseger H, et al.

MMWR Morbidity and mortality weekly report. 2020;69(15):472-6.

132. One Health-based control strategies for MERS-CoV. Hemida M. Journal of Infection and Public Health.

2020;13(2):373.

133. COVID-19: faecal–oral transmission? Hindson J. Nature Reviews Gastroenterology and Hepatology.

2020;17(5):259.

134. Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19. Hoang VT, Dao TL, Gautret P.

J Med Virol. 2020. http://dx.doi.org/10.1002/jmv.26056.

135. New paths for sustainable solutions to tackle global and emerging infectious threats. Holm A.

Biologicals. 2020.

136. Biological plausibility for interactions between dietary fat, resveratrol, ACE2, and SARS-CoV illness

severity. Horne JR, Vohl MC. American journal of physiology Endocrinology and metabolism. 2020;318(5):E830-E3.

137. Radiology perspective of coronavirus disease 2019 (COVID-19): Lessons from severe acute respiratory

syndrome and Middle East respiratory syndrome. Hosseiny M, Kooraki S, Gholamrezanezhad A, Reddy S, Myers L.

American Journal of Roentgenology. 2020;214(5):1078-82.

138. Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19. Hu

X, Xing Y, Jia J, Ni W, Liang J, Zhao D, et al. Science of the Total Environment. 2020;728.

139. A report of three COVID-19 cases with prolonged viral RNA detection in anal swabs. Hu Y, Shen L, Yao

Y, Xu Z, Zhou J, Zhou H. Clinical Microbiology and Infection. 2020.

140. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts

in Nanjing, China. Hu Z, Song C, Xu C, Jin G, Chen Y, Xu X, et al. Science China Life sciences. 2020;63(5):706-11.

141. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Huang C, Wang Y,

Li X, Ren L, Zhao J, Hu Y, et al. The Lancet. 2020;395(10223):497-506.

142. Chronological Changes of Viral Shedding in Adult Inpatients with COVID-19 in Wuhan, China. Huang

JT, Ran RX, Lv ZH, Feng LN, Ran CY, Tong YQ, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa631.

143. Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong

infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients

with COVID-19: A prospective contact-tracing study. Huang L, Zhang X, Zhang X, Wei Z, Zhang L, Xu J, et al.

Journal of Infection. 2020.

144. RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2. Huang WE, Lim B, Hsu CC, Xiong D, Wu W, Yu

Y, et al. Microbial Biotechnology. 2020.

145. Emergent strategies for the next phase of covid-19. Huh K, Shin HS, Peck KR. Infection and

Chemotherapy. 2020;52(1):105-9.

146. Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of

patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Hung IFN, Lung KC, Tso

EYK, Liu R, Chung TWH, Chu MY, et al. Lancet (London, England). 2020.

147. SARS – CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using

trivalent vaccine (tetanus, diphtheria and Bordetella pertussis). Ietto G. Medical Hypotheses. 2020;141.

148. Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and

IgG antibodies: an Italian experience. Infantino M, Grossi V, Lari B, Bambi R, Perri A, Manneschi M, et al. Journal of

medical virology. 2020.

149. A fourteen-day experience with coronavirus disease 2019 (COVID-19) induced acute respiratory

distress syndrome (ARDS): An Iranian treatment protocol. Jamaati H, Dastan F, Tabarsi P, Marjani M, Saffaei A,

Hashemian SM. Iranian Journal of Pharmaceutical Research. 2020;19(1):31-6.

150. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a

retrospective cohort study. Javanian M, Bayani M, Shokri M, Sadeghi-Haddad-Zavareh M, Babazadeh A, Yeganeh B,

et al. Romanian journal of internal medicine = Revue roumaine de medecine interne. 2020.

151. Covid-19: should the public wear face masks? Javid B, Weekes MP, Matheson NJ. The BMJ. 2020;369.

152. Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in

Taizhou, China. Jiang Y, He S, Zhang C, Wang X, Chen X, Jin Y, et al. Ann Transl Med. 2020;8(8):547.

http://dx.doi.org/10.21037/atm.2020.04.20.

153. Characteristics of a family cluster of Severe Acute Respiratory Syndrome Coronavirus 2 in Henan,

China. Jiang Y, Niu W, Wang Q, Zhao H, Meng L, Zhang C. J Infect. 2020. http://dx.doi.org/10.1016/j.jinf.2020.04.028.

154. Erythema multiforme-like eruption in patients with COVID-19 infection: clinical and histological

findings. Jimenez-Cauhe J, Ortega-Quijano D, Carretero-Barrio I, Suarez-Valle A, Saceda-Corralo D, Moreno-Garcia

Del Real C, et al. Clinical and experimental dermatology. 2020.

155. Re: Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19. Jung J,

Oh DK, An JH, Hong SB, Sung H, Kim MN, et al. The Journal of infection. 2020.

156. Interventions for treatment of COVID-19: a protocol for a living systematic review with network

meta-analysis including individual patient data (The LIVING Project). Juul S, Nielsen N, Bentzer P, Veroniki AA,

Thabane L, Linder A, et al. Systematic reviews. 2020;9(1):108.

157. A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic

Coronavirus Disease 2019 (COVID-19). Kakodkar P, Kaka N, Baig MN. Cureus. 2020;12(4):e7560.

http://dx.doi.org/10.7759/cureus.7560.

158. SARS-CoV-2 Shedding from Asymptomatic Patients: Contribution of Potential Extrapulmonary Tissue

Reservoirs. Kalkeri R, Goebel S, Sharma GD. The American journal of tropical medicine and hygiene. 2020.

159. COVID-19 in People with Mental Illness: Challenges and Vulnerabilities. Kavoor AR. Asian Journal of

Psychiatry. 2020;51.

160. Modeling the effects of intervention strategies on COVID-19 transmission dynamics. Kennedy DM,

Zambrano GJ, Wang Y, Neto OP. Journal of clinical virology : the official publication of the Pan American Society for

Clinical Virology. 2020;128:104440. http://dx.doi.org/10.1016/j.jcv.2020.104440.

161. An Epidemiological Study on COVID-19: A Rapidly Spreading Disease. Khachfe HH, Chahrour M,

Sammouri J, Salhab H, Makki BE, Fares M. Cureus. 2020;12(3):e7313. http://dx.doi.org/10.7759/cureus.7313.

162. Middle east respiratory syndrome coronavirus transmission. Killerby ME, Biggs HM, Midgley CM, Gerber

SI, Watson JT. Emerging Infectious Diseases. 2020;26(2):191-8.

163. Clinical Course and Outcomes of Patients with Severe Acute Respiratory Syndrome Coronavirus 2

Infection: a Preliminary Report of the First 28 Patients from the Korean Cohort Study on COVID-19. Kim ES,

Chin BS, Kang CK, Kim NJ, Kang YM, Choi JP, et al. Journal of Korean medical science. 2020;35(13):e142.

164. Crystal structure of Nsp15 endoribonuclease NendoU from SARS-CoV-2. Kim Y, Jedrzejczak R, Maltseva

NI, Wilamowski M, Endres M, Godzik A, et al. Protein Science. 2020.

165. Infection and Rapid Transmission of SARS-CoV-2 in Ferrets. Kim YI, Kim SG, Kim SM, Kim EH, Park SJ, Yu

KM, et al. Cell Host and Microbe. 2020;27(5):704-9.e2.

166. Pediatric Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection – UAE. Kindi FA, Nair

SC, Hashmey R. Journal of Infection and Public Health. 2020;13(2):372.

167. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Kissler SM,

Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Science. 2020;368(6493):860-8.

http://dx.doi.org/10.1126/science.abb5793. Epub 2020 Apr 14.

168. Communicating the risk of death from novel coronavirus disease (COVID-19). Kobayashi T, Jung SM,

Linton NM, Kinoshita R, Hayashi K, Miyama T, et al. Journal of Clinical Medicine. 2020;9(2).

169. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Kotfis K, Williams Roberson S,

Wilson JE, Dabrowski W, Pun BT, Ely EW. Critical Care. 2020;24(1).

170. Can SARS-CoV-2-infected women breastfeed after viral clearance? Lang GJ, Zhao H. Journal of Zhejiang

University: Science B. 2020.

171. Host factors affecting generation of immunity against porcine epidemic diarrhea virus in pregnant

and lactating swine and passive protection of neonates. Langel SN, Wang Q, Vlasova AN, Saif LJ. Pathogens.

2020;9(2).

172. Middle east respiratory syndrome coronavirus antibodies in bactrian and hybrid camels from Dubai.

Lau SKP, Li KSM, Luk HKH, He Z, Teng JLL, Yuen KY, et al. mSphere. 2020;5(1).

173. New coronavirus outbreak: Framing questions for pandemic prevention. Layne SP, Hyman JM, Morens

DM, Taubenberger JK. Science Translational Medicine. 2020;12(534).

174. Severe Acute Respiratory Syndrome Coronavirus 2 Shedding by Travelers, Vietnam, 2020. Le TQM,

Takemura T, Moi ML, Nabeshima T, Nguyen LKH, Hoang VMP, et al. Emerging infectious diseases. 2020;26(7).

175. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic

review of the literature, case series, and recommendations for clinical assessment and management. Lechner

M, Chandrasekharan D, Jumani K, Liu J, Gane S, Lund VJ, et al. Rhinology. 2020.

176. Mitigation of Head and Neck Cancer Service Disruption During COVID-19 in Hong Kong Through

Telehealth and Multi-institution Collaboration. Lee AK, R.H.C FR, E.H.L FR, Cheng HK, Fanzca, E.W.W FR, et al. Head

& neck. 2020.

177. A Lesson from Temporary Closing of a Single University-affiliated Hospital owing to In-Hospital

Transmission of Coronavirus Disease 2019. Lee H, Heo JW, Kim SW, Lee J, Choi JH. Journal of Korean medical

science. 2020;35(13):e145.

178. A cross-sectional comparison of epidemiological and clinical features of patients with coronavirus

disease (COVID-19) in Wuhan and outside Wuhan, China. Lei Z, Cao H, Jie Y, Huang Z, Guo X, Chen J, et al. Travel

Medicine and Infectious Disease. 2020.

179. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lescure FX,

Bouadma L, Nguyen D, Parisey M, Wicky PH, Behillil S, et al. The Lancet Infectious diseases. 2020.

180. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and

second-wave scenario planning: a modelling impact assessment. Leung K, Wu JT, Liu D, Leung GM. The Lancet.

2020;395(10233):1382-93.

181. Respiratory virus shedding in exhaled breath and efficacy of face masks. Leung NHL, Chu DKW, Shiu

EYC, Chan KH, McDevitt JJ, Hau BJP, et al. Nature Medicine. 2020.

182. Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in

California and Washington: prospective cohort study. Lewnard JA, Liu VX, Jackson ML, Schmidt MA, Jewell BL,

Flores JP, et al. Bmj. 2020;369:m1923. http://dx.doi.org/10.1136/bmj.m1923.

183. SARS-CoV-2 infection-induced immune responses: friends or foes? Li K, Hao Z, Zhao X, Du J, Zhou Y.

Scandinavian journal of immunology. 2020:e12895. http://dx.doi.org/10.1111/sji.12895.

184. Single-dose, intranasal immunization with recombinant parainfluenza virus 5 expressing middle east

respiratory syndrome coronavirus (Mers-cov) spike protein protects mice from fatal mers-cov infection. Li K, Li

Z, Wohlford-Lenane C, Meyerholz DK, Channappanavar R, An D, et al. mBio. 2020;11(2).

185. Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon. Li N, Wang X, Lv T. Journal of medical

virology. 2020.

186. Disease control of 2019-novel coronavirus infection in hospital: West China urgent recommendation.

Li S, Huang W, Liao X, Li D, Du L, Song J, et al. Chinese Journal of Evidence-Based Medicine. 2020;20(2):125-33.

187. EZH2-mediated H3K27me3 inhibits ACE2 expression. Li Y, Li H, Zhou L. Biochemical and Biophysical

Research Communications. 2020;526(4):947-52.

188. Emerging lethal infectious bronchitis coronavirus variants with multiorgan tropism. Li YT, Chen TC, Lin

SY, Mase M, Murakami S, Horimoto T, et al. Transboundary and Emerging Diseases. 2020;67(2):884-93.

189. Prevention and control of novel coronavirus infection in department of stomatology. Li ZY, Meng LY.

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology.

2020;55(4):217-22.

190. Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease

2019: a retrospective study. Lian N, Xie H, Lin S, Huang J, Zhao J, Lin Q. Clinical Microbiology and Infection. 2020.

191. Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the

Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by

Quantitative RT-PCR. Lim J, Jeon S, Shin HY, Kim MJ, Seong YM, Lee WJ, et al. Journal of Korean medical science.

2020;35(6):e79.

192. Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Ling

Y, Xu SB, Lin YX, Tian D, Zhu ZQ, Dai FH, et al. Chinese medical journal. 2020;133(9):1039-43.

193. Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019

(COVID-19). Lippi G, Henry BM, Bovo C, Sanchis-Gomar F. Diagnosis (Berlin, Germany). 2020;7(2):85-90.

http://dx.doi.org/10.1515/dx-2020-0041.

194. Defining the epidemiology of Covid-19 - Studies needed. Lipsitch M, Swerdlow DL, Finelli L. New England

Journal of Medicine. 2020;382(13):1194-6.

195. Impact of meteorological factors on the COVID-19 transmission: A multi-city study in China. Liu J,

Zhou J, Yao J, Zhang X, Li L, Xu X, et al. Science of the Total Environment. 2020;726.

196. [Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia]. Liu M, He P,

Liu HG, Wang XJ, Li FJ, Chen S, et al. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal

of tuberculosis and respiratory diseases. 2020;43(3):209-14.

http://dx.doi.org/10.3760/cma.j.issn.1001-0939.2020.03.014.

197. Prolonged virus shedding even after seroconversion in a patient with COVID-19. Liu WD, Chang SY,

Wang JT, Tsai MJ, Hung CC, Hsu CL, et al. Journal of Infection. 2020.

198. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung

injury. Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Science China Life sciences. 2020;63(3):364-74.

199. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential

intermediate hosts of SARS-CoV-2. Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, et al. Journal of Medical Virology.

2020;92(6):595-601.

200. Evaluation of SARS-CoV-2 RNA shedding in clinical specimens and clinical characteristics of 10

patients with COVID-19 in Macau. Lo IL, Lio CF, Cheong HH, Lei CI, Cheong TH, Zhong X, et al. International journal

of biological sciences. 2020;16(10):1698-707.

201. Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2

(SARS-CoV-2) infection: a question needing an answer. Lombardi A, Bozzi G, Mangioni D, Muscatello A, Peri AM,

Taramasso L, et al. The Journal of hospital infection. 2020. http://dx.doi.org/10.1016/j.jhin.2020.03.003.

202. A “One-Health” approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy.

Lorusso A, Calistri P, Mercante MT, Monaco F, Portanti O, Marcacci M, et al. One Health. 2020;10.

203. Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset. Lou B, Li TD,

Zheng SF, Su YY, Li ZY, Liu W, et al. The European respiratory journal. 2020.

http://dx.doi.org/10.1183/13993003.00763-2020.

204. Features of patients with 2019 novel coronavirus admitted in a pneumology department: The first

retrospective Tunisian case series. Louhaichi S, Allouche A, Baili H, Jrad S, Radhouani A, Greb D, et al. Tunisie

Medicale. 2020;98(4):261-5.

205. The Wuhan SARS-CoV-2—What's next for China. Lu H, Stratton CW, Tang YW. Journal of Medical

Virology. 2020;92(6):546-7.

206. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. Lu H,

Stratton CW, Tang YW. Journal of Medical Virology. 2020;92(4):401-2.

207. Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China. Lu J, du Plessis L, Liu Z, Hill V,

Kang M, Lin H, et al. Cell. 2020. http://dx.doi.org/10.1016/j.cell.2020.04.023.

208. Symptomatic Infection is Associated with Prolonged Duration of Viral Shedding in Mild Coronavirus

Disease 2019: A Retrospective Study of 110 Children in Wuhan. Lu Y, Li Y, Deng W, Liu M, He Y, Huang L, et al.

The Pediatric infectious disease journal. 2020.

209. Children are unlikely to be the main drivers of the COVID-19 pandemic - a systematic review.

Ludvigsson JF. Acta paediatrica (Oslo, Norway : 1992). 2020. http://dx.doi.org/10.1111/apa.15371.

210. Treatment efficacy analysis of traditional Chinese medicine for novel coronavirus pneumonia

(COVID-19): An empirical study from Wuhan, Hubei Province, China. Luo E, Zhang D, Luo H, Liu B, Zhao K, Zhao

Y, et al. Chinese Medicine (United Kingdom). 2020;15(1).

211. Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of

Historical Classics, Research Evidence and Current Prevention Programs. Luo H, Tang QL, Shang YX, Liang SB,

Yang M, Robinson N, et al. Chinese Journal of Integrative Medicine. 2020;26(4):243-50.

212. Nosocomial infection with SARS-Cov-2 within Departments of Digestive Surgery. Luong-Nguyen M,

Hermand H, Abdalla S, Cabrit N, Hobeika C, Brouquet A, et al. Journal of visceral surgery. 2020.

213. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic. Luzi L, Radaelli MG.

Acta Diabetologica. 2020;57(6):759-64.

214. Do children need a longer time to shed SARS-CoV-2 in stool than adults? Ma X, Su L, Zhang Y, Zhang X,

Gai Z, Zhang Z. Journal of Microbiology, Immunology and Infection. 2020.

215. Preventing adverse cutaneous reactions from amplified hygiene practices during the COVID-19

pandemic: how dermatologists can help through anticipatory guidance. MacGibeny MA, Wassef C. Archives of

dermatological research. 2020.

216. Need of the Hour- COVID-19 for Cardiologists. Maddury J, Paramjyothi GK. Indian Journal of

Cardiovascular Disease in Women - WINCARS. 2020;5(1):04-7.

217. Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-converting Enzyme 2 as

a Potential Drug Target - A Perspective. Magrone T, Magrone M, Jirillo E. Endocrine, metabolic & immune disorders

drug targets. 2020.

218. COVID-19 in intensive care. Some necessary steps for health care workers. Malhotra N, Gupta N, Ish S,

Ish P. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. 2020;90(1).

http://dx.doi.org/10.4081/monaldi.2020.1284.

219. Coronavirus threat to Indian population: risk factors, transmission dynamics and preparedness to

prevent the spread of the virus. Mandal D. VirusDisease. 2020.

220. Primary care management of the coronavirus (Covid-19). Mash B. South African Family Practice.

2020;62(1).

221. Coronavirus Disease (COVID-19) and the Gastrointestinal System in Children. Matthai J, Shanmugam N,

Sobhan P. Indian pediatrics. 2020.

222. Coronavirus disease 2019 treatment: A review of early and emerging options. McCreary EK, Pogue JM.

Open Forum Infectious Diseases. 2020;7(4).

223. Urgent need for individual mobile phone and institutional reporting of at home, hospitalized, and

intensive care unit cases of SARS-CoV-2 (COVID-19) infection. McCullough PA, Eidt J, Rangaswami J, Lerma E,

Tumlin J, Wheelan K, et al. Reviews in cardiovascular medicine. 2020;21(1):1-7.

224. The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage

Activation Syndrome-Like Disease. McGonagle D, Sharif K, O'Regan A, Bridgewood C. Autoimmunity Reviews. 2020.

225. Utility of Tracheostomy in Patients With COVID-19 and Other Special Considerations. Mecham JC,

Thomas OJ, Pirgousis P, Janus JR. The Laryngoscope. 2020. http://dx.doi.org/10.1002/lary.28734.

226. Fecal Shedding of SARS CoV-2: Implications for Disease Spread and Quarantine. Meena J, Kumar J.

Indian pediatrics. 2020.

227. Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with

hypertension. Meng J, Xiao G, Zhang J, He X, Ou M, Bi J, et al. Emerging microbes & infections. 2020;9(1):757-60.

228. Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine.

Meng L, Hua F, Bian Z. Journal of dental research. 2020:22034520914246.

229. COVID-19 outbreak in Iraqi Kurdistan: The first report characterizing epidemiological, clinical,

laboratory, and radiological findings of the disease. Merza MA, Haleem Al Mezori AA, Mohammed HM, Abdulah

DM. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):547-54.

230. SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor. Messina F, Piaserico S. Journal

of the European Academy of Dermatology and Venereology. 2020.

231. Full-length title: Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A

retrospective analysis of 1061 cases in Marseille, France. Million M, Lagier JC, Gautret P, Colson P, Fournier PE,

Amrane S, et al. Travel medicine and infectious disease. 2020:101738.

232. Panic of buying toilet papers: A historical memory or a horrible truth? systematic review of

gastrointestinal manifestations of COVID-19. Miri SM, Roozbeh F, Omranirad A, Alavian SM. Hepatitis Monthly.

2020;20(3).

233. Use of antiviral drugs to reduce COVID-19 transmission. Mitjà O, Clotet B. The Lancet Global Health.

2020;8(5):e639-e40.

234. Preparation and response to COVID-19 outbreak in Singapore: A case report. Monica FPE, Aloweni F,

Yuh AS, Ayob EBM, Ahmad NB, Lan CJ, et al. Infection, Disease and Health. 2020.

235. Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute

Respiratory Infections Caused by 2019-nCoV. Morse JS, Lalonde T, Xu S, Liu WR. ChemBioChem. 2020;21(5):730-8.

236. Time Course of COVID-19 Cases in Austria. Moshammer H, Poteser M, Lemmerer K, Wallner P, Hutter HP.

International journal of environmental research and public health. 2020;17(9).

http://dx.doi.org/10.3390/ijerph17093270.

237. Time, distance, shielding and ALARA; drawing similarities between measures for radiation protection

and Coronavirus disease pandemic response. Mukherji A, Gupta T, Agarwal JP. Indian journal of cancer.

2020;57(2):221-3. http://dx.doi.org/10.4103/ijc.IJC_343_20.

238. Covid-19 outbreak on Malawi perspective. Munthali GNC, Xuelian W. Electronic Journal of General

Medicine. 2020;17(4):1-3.

239. Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and

Meta-Analysis. Mustafa NM, L AS. Journal of Clinical Virology. 2020;128.

240. Molecular evolution and structural mapping of N-terminal domain in spike gene of middle east

respiratory syndrome coronavirus (MERS-CoV). Naeem A, Hamed ME, Alghoribi MF, Aljabr W, Alsaran H, Enani

MA, et al. Viruses. 2020;12(5).

241. A sporadic COVID-19 pneumonia treated with extracorporeal membrane oxygenation in Tokyo,

Japan: A case report. Nakamura K, Hikone M, Shimizu H, Kuwahara Y, Tanabe M, Kobayashi M, et al. Journal of

Infection and Chemotherapy. 2020.

242. Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019

novel Coronavirus. Ngonghala CN, Iboi E, Eikenberry S, Scotch M, MacIntyre CR, Bonds MH, et al. Mathematical

biosciences. 2020;325:108364. http://dx.doi.org/10.1016/j.mbs.2020.108364.

243. Coronavirus disease (COVID-19) in a paucisymptomatic patient: Epidemiological and clinical challenge

in settings with limited community transmission, Italy, February 2020. Nicastri E, D'Abramo A, Faggioni G, De

Santis R, Mariano A, Lepore L, et al. Eurosurveillance. 2020;25(11).

244. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Nishiura H,

Kobayashi T, Miyama T, Suzuki A, Jung SM, Hayashi K, et al. International Journal of Infectious Diseases.

2020;94:154-5.

245. Investiagation of possible mechanism of eye transmission of SARS-CoV-2 based on SARS-CoV. Niu FL,

Ku NN, Sun Y. International Eye Science. 2020;20(4):729-32.

246. Clinical characteristics of older patients infected with COVID-19: A descriptive study. Niu S, Tian S, Lou

J, Kang X, Zhang L, Lian H, et al. Archives of Gerontology and Geriatrics. 2020;89.

247. Asymptomatic infection and atypical manifestations of COVID-19: comparison of viral shedding

duration. Noh JY, Yoon JG, Seong H, Choi WS, Sohn JW, Cheong HJ, et al. The Journal of infection.

2020:S0163-4453(20)30310-8.

248. COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?

Novi G, Mikulska M, Briano F, Toscanini F, Tazza F, Uccelli A, et al. Multiple Sclerosis and Related Disorders. 2020;42.

249. What's New With the Old Coronaviruses? Ogimi C, Kim YJ, Martin ET, Huh HJ, Chiu CH, Englund JA.

Journal of the Pediatric Infectious Diseases Society. 2020;9(2):210-7.

250. Management of a radiotherapy center during the COVID-19 outbreak: The experience of the

Mulhouse hospital centre (France). Ohnleiter T, Piot L, Rogenmuser A, Noirclerc M, Hamlaoui R, Grandgirard A.

Cancer/Radiotherapie. 2020.

251. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute

Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from a Symptomatic Patient. Ong SWX, Tan YK, Chia PY, Lee

TH, Ng OT, Wong MSY, et al. JAMA - Journal of the American Medical Association. 2020;323(16):1610-2.

252. Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the

outbreak period. Ozma MA, Maroufi P, Khodadadi E, Köse Ş, Esposito I, Ganbarov K, et al. Le infezioni in medicina.

2020;28(2):153-65.

253. Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab.

Paoli D, Pallotti F, Colangelo S, Basilico F, Mazzuti L, Turriziani O, et al. Journal of Endocrinological Investigation. 2020.

254. Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery. Parhar

HS, Tasche K, Brody RM, Weinstein GS, O'Malley BW, Shanti RM, et al. Head and Neck. 2020.

255. The time scale of asymptomatic transmission affects estimates of epidemic potential in the COVID-19

outbreak. Park SW, Cornforth DM, Dushoff J, Weitz JS. Epidemics. 2020;31.

256. Patients with COVID-19: are current isolation guidelines effective enough? Patel KP, Patel PA, Vunnam

SR, Jain R, Vunnam RR. Public Health. 2020;183:38-9.

257. Coronavirus Infections-More Than Just the Common Cold. Paules CI, Marston HD, Fauci AS. JAMA -

Journal of the American Medical Association. 2020;323(8):707-8.

258. SARS-CoV-2: A storm is raging. Pedersen SF, Ho YC. Journal of Clinical Investigation. 2020;130(5):2202-5.

259. Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes. Peng H,

Gao P, Xu Q, Liu M, Peng J, Wang Y, et al. Journal of clinical virology : the official publication of the Pan American

Society for Clinical Virology. 2020;128:104425. http://dx.doi.org/10.1016/j.jcv.2020.104425.

260. [Tracheostomy during novel corona virus pandemic]. Perényi Á, Sztanó B, Bella Z, Szegesdi I, Csanády M,

Kelemen É, et al. Orvosi hetilap. 2020;161(19):767-70. http://dx.doi.org/10.1556/650.2020.31832.

261. Clinical course of severe and critical COVID-19 in hospitalized pregnancies: a US cohort study.

Pierce-Williams RAM, Burd J, Felder L, Khoury R, Bernstein PS, Avila K, et al. American journal of obstetrics &

gynecology MFM. 2020:100134. http://dx.doi.org/10.1016/j.ajogmf.2020.100134.

262. Nipah virus: Past outbreaks and future containment. Pillai VS, Krishna G, Veettil MV. Viruses. 2020;12(4).

263. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study]. Plaze M, Attali D, Petit

AC, Blatzer M, Simon-Loriere E, Vinckier F, et al. Encephale. 2020. http://dx.doi.org/10.1016/j.encep.2020.04.010.

264. Tortoises, hares, and vaccines: A cautionary note for SARS-CoV-2 vaccine development. Poland GA.

Vaccine. 2020;38(27):4219-20.

265. A Surgical Safety Checklist for Performing Tracheotomy in Patients with Coronavirus Disease 19.

Portugal LG, Adams DR, Baroody FM, Agrawal N. Otolaryngology--head and neck surgery : official journal of American

Academy of Otolaryngology-Head and Neck Surgery. 2020:194599820922981.

http://dx.doi.org/10.1177/0194599820922981.

266. The suspected SARS-Cov-2 infection in a Charcot-Marie-Tooth patient undergoing postsurgical

rehabilitation: the value of telerehabilitation for evaluation and continuing treatment. Prada V, Bellone E,

Schenone A, Grandis M. International journal of rehabilitation research Internationale Zeitschrift fur

Rehabilitationsforschung Revue internationale de recherches de readaptation. 2020.

267. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in

Wuhan, China: a modelling study. Prem K, Liu Y, Russell TW, Kucharski AJ, Eggo RM, Davies N, et al. The Lancet

Public Health. 2020;5(5):e261-e70.

268. Quantifying the Impact of COVID-19 on Cancer Patients: A Technical Report of Patient Experience

During the COVID-19 Pandemic at a High-volume Radiation Oncology Proton Center in New York City. Press

RH, Hasan S, Chhabra AM, Choi JI, Simone CB, 2nd. Cureus. 2020;12(4):e7873. http://dx.doi.org/10.7759/cureus.7873.

269. Canine Respiratory Coronavirus: A Naturally Occurring Model of COVID-19? Priestnall SL. Veterinary

Pathology. 2020.

270. Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response

measures. Pung R, Chiew CJ, Young BE, Chin S, Chen MIC, Clapham HE, et al. The Lancet. 2020;395(10229):1039-46.

271. Influenza virus like particles (VLPs): Opportunities for H7N9 vaccine development. Pushko P,

Tretyakova I. Viruses. 2020;12(5).

272. Factors associated with duration of viral shedding in adults with COVID-19 outside of Wuhan, China:

A retrospective cohort study. Qi L, Yang Y, Jiang D, Tu C, Wan L, Chen X, et al. International journal of infectious

diseases : IJID : official publication of the International Society for Infectious Diseases. 2020.

273. Duration of SARS-CoV-2 viral shedding during COVID-19 infection. Qian GQ, Chen XQ, Lv DF, Ma AHY,

Wang LP, Yang NB, et al. Infectious Diseases. 2020.

274. Fighting against the common enemy of COVID-19: A practice of building a community with a shared

future for mankind. Qian X, Ren R, Wang Y, Guo Y, Fang J, Wu ZD, et al. Infectious Diseases of Poverty. 2020;9(1).

275. Coronavirus disease 2019 in pregnancy. Qiancheng X, Jian S, Lingling P, Lei H, Xiaogan J, Weihua L, et al.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious

Diseases. 2020.

276. Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients,

China. Qiu C, Deng Z, Xiao Q, Shu Y, Deng Y, Wang H, et al. Journal of Medical Virology. 2020.

277. A Typical Case of Critically Ill Infant of Coronavirus Disease 2019 With Persistent Reduction of T

Lymphocytes. Qiu L, Jiao R, Zhang A, Chen X, Ning Q, Fang F, et al. The Pediatric infectious disease journal. 2020.

278. COVID-19: The environmental implications of shedding SARS-CoV-2 in human faeces. Quilliam RS,

Weidmann M, Moresco V, Purshouse H, O'Hara Z, Oliver DM. Environment international. 2020;140:105790.

279. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against

Sars-Cov-2 infection (COVID-19): A role for iron homeostasis? Quiros Roldan E, Biasiotto G, Magro P, Zanella I.

Pharmacological research. 2020;158.

280. Global coronavirus pandemic (2019-nCOV): Implication for an Italian medium size dermatological

clinic of a ii level hospital. Radi G, Diotallevi F, Campanati A, Offidani A. Journal of the European Academy of

Dermatology and Venereology. 2020.

281. [Opportunity of periodic monitoring of COVID-19 patients, asymptomatic virus carriers, and

postinfectious individuals with IgM/IgG rapid antibody tests among healthcare workers during SARS-CoV-2

pandemic]. Ragó Z, Szijjártó L, Duda E, Bella Z. Orvosi hetilap. 2020;161(21):854-60.

http://dx.doi.org/10.1556/650.2020.31862.

282. Challenges of managing the asymptomatic carriers of SARS-CoV-2. Rahimi F, Talebi Bezmin Abadi A.

Travel Medicine and Infectious Disease. 2020.

283. Coronavirus as silent killer: recent advancement to pathogenesis, therapeutic strategy and future

perspectives. Raj K, Rohit, Ghosh A, Singh S. VirusDisease. 2020.

284. A surgeon's role in fighting a medical pandemic: Experiences from the unit at the epicentre of

COVID-19 in Singapore - A cohort perspective. Rasappan K, Oh JYL, Ding BTK, Mohd Fadhil MF, Lee KT.

International journal of surgery (London, England). 2020;79:31-5. http://dx.doi.org/10.1016/j.ijsu.2020.05.033.

285. Coronavirus Disease 2019 (COVID-19): A critical care perspective beyond China. Rello J, Tejada S,

Userovici C, Arvaniti K, Pugin J, Waterer G. Anaesthesia Critical Care and Pain Medicine. 2020;39(2):167-9.

286. Stability and infectivity of coronaviruses in inanimate environments. Ren SY, Wang WB, Hao YG, Zhang

HR, Wang ZC, Chen YL, et al. World journal of clinical cases. 2020;8(8):1391-9.

http://dx.doi.org/10.12998/wjcc.v8.i8.1391.

287. Potential impact of seasonal forcing on a SARS-CoV-2 pandemic. Richard NA, Robert D, Valentin D,

Emma HB, Jan A. Swiss Medical Weekly. 2020;150(11).

288. Hydroxychloroquine effects on psoriasis: a systematic review and a cautionary note for COVID-19

treatment. Sachdeva M, Mufti A, Maliyar K, Lytvyn Y, Yeung J. Journal of the American Academy of Dermatology.

2020. http://dx.doi.org/10.1016/j.jaad.2020.05.074.

289. Upheaval in cancer care during the COVID-19 outbreak. Salako O, Okunade K, Allsop M, Habeebu M,

Toye M, Oluyede G, et al. ecancermedicalscience. 2020;14.

290. COVID-19 in Children: Clinical Approach and Management. Sankar J, Dhochak N, Kabra SK, Lodha R.

Indian Journal of Pediatrics. 2020;87(6):433-42.

291. Repurposing antimalarials and other drugs for COVID-19. Schlagenhauf P, Grobusch MP, Maier JD,

Gautret P. Travel Medicine and Infectious Disease. 2020;34.

292. First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

in a pediatric dialysis unit. Schwierzeck V, König JC, Kühn J, Mellmann A, Correa-Martínez CL, Omran H, et al. Clinical

infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.

293. First Mildly Ill, Non-Hospitalized Case of Coronavirus Disease 2019 (COVID-19) Without Viral

Transmission in the United States - Maricopa County, Arizona, 2020. Scott SE, Zabel K, Collins J, Hobbs KC,

Kretschmer MJ, Lach M, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of

America. 2020.

294. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients.

Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE, et al. Ophthalmology. 2020.

295. In ovo delivered toll-like receptor 7 ligand, resiquimod enhances host responses against infectious

bronchitis corona virus (IBV) infection. Senapathi UDS, Aboelkhair M, Puro K, Ali M, Amarasinghe A, Sarjoon

Abdul-Cader M, et al. Vaccines. 2020;8(2).

296. Airborne transmission route of covid-19: Why 2 meters/6 feet of inter-personal distance could not be

enough. Setti L, Passarini F, De Gennaro G, Barbieri P, Perrone MG, Borelli M, et al. International Journal of

Environmental Research and Public Health. 2020;17(8).

297. COVID-19 and Neonatal Respiratory Care: Current Evidence and Practical Approach. Shalish W,

Lakshminrusimha S, Manzoni P, Keszler M, Sant'Anna GM. American journal of perinatology. 2020.

http://dx.doi.org/10.1055/s-0040-1710522.

298. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell

cultures and multiple coronaviruses in mice. Sheahan TP, Sims AC, Zhou S, Graham RL, Pruijssers AJ, Agostini ML,

et al. Science translational medicine. 2020;12(541). http://dx.doi.org/10.1126/scitranslmed.abb5883. Epub 2020 Apr 6.

299. Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma. Shen C, Wang Z, Zhao F,

Yang Y, Li J, Yuan J, et al. JAMA - Journal of the American Medical Association. 2020;323(16):1582-9.

300. Novel coronavirus infection in children outside of Wuhan, China. Shen Q, Guo W, Guo T, Li J, He W, Ni S,

et al. Pediatric Pulmonology. 2020.

301. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Sia SF, Yan LM, Chin AWH, Fung K,

Choy KT, Wong AYL, et al. Nature. 2020.

302. Antenatal corticosteroid therapy and COVID-19 : pathophysiological considerations. Sichitiu J, Fakhouri

F, Desseauve D. Acta Obstetricia et Gynecologica Scandinavica. 2020.

303. “Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.”. Singh AK,

Singh A, Singh R, Misra A. Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2020;14(4):589-96.

304. The research community must meet the coronavirus disease 2019 challenge. Singh PK. Indian Journal of

Medical Research, Supplement. 2020;151(2):116-7.

305. Zinc and respiratory tract infections: Perspectives for COVID‑19 (Review). Skalny AV, Rink L, Ajsuvakova

OP, Aschner M, Gritsenko VA, Alekseenko SI, et al. International journal of molecular medicine. 2020.

http://dx.doi.org/10.3892/ijmm.2020.4575.

306. Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment. Smieszek SP,

Przychodzen BP, Polymeropoulos MH. International Journal of Antimicrobial Agents. 2020.

307. COVID-19: focus on the lungs but do not forget the gastrointestinal tract. Smyk W, Janik MK, Portincasa

P, Milkiewicz P, Lammert F, Krawczyk M. European journal of clinical investigation. 2020:e13276.

308. Recommendations from the CSO-HNS taskforce on performance of tracheotomy during the

COVID-19 pandemic. Sommer DD, Engels PT, Weitzel EK, Khalili S, Corsten M, Tewfik MA, et al. Journal of

otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale.

2020;49(1):23. http://dx.doi.org/10.1186/s40463-020-00414-9.

309. Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid

arthritis receiving conventional disease-modifying antirheumatic drugs. Song J, Kang S, Choi SW, Seo KW, Lee S,

So MW, et al. Rheumatology International. 2020;40(6):991-5.

310. Clinical and epidemiological features of COVID-19 family clusters in Beijing, China. Song R, Han B,

Song M, Wang L, Conlon CP, Dong T, et al. Journal of Infection. 2020.

311. Benefits of exercise on influenza or pneumonia in older adults: A systematic review. Song Y, Ren F, Sun

D, Wang M, Baker JS, István B, et al. International Journal of Environmental Research and Public Health. 2020;17(8).

312. Impact of new coronavirus epidemics on HIV-infected patients. Soriano V, Barreiro P. AIDS Reviews.

2020;22(1):57-8.

313. Structural genomics of SARS-COV-2 indicates evolutionary conserved functional regions of viral

proteins. Srinivasan S, Cui H, Gao Z, Liu M, Lu S, Mkandawire W, et al. Viruses. 2020;12(4).

314. Are Covid-19-positive mothers dangerous for their term and well newborn babies? Is there an

answer? Stanojević M. Journal of perinatal medicine. 2020.

315. First cases of coronavirus disease 2019 (COVID-19) in France: Surveillance, investigations and control

measures, January 2020. Stoecklin SB, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, et al. Eurosurveillance.

2020;25(6).

316. Transmission risk of patients with COVID-19 meeting discharge criteria should be interpreted with

caution. Su JW, Wu WR, Lang GJ, Zhao H, Sheng JF. Journal of Zhejiang University: Science B. 2020.

317. The different clinical characteristics of corona virus disease cases between children and their families

in China–the character of children with COVID-19. Su L, Ma X, Yu H, Zhang Z, Bian P, Han Y, et al. Emerging

Microbes and Infections. 2020;9(1):707-13.

318. Prevention and therapy of covid-19 via exogenous estrogen treatment for both male and female

patients; An opinion paper. Suba Z. Journal of Pharmacy and Pharmaceutical Sciences. 2020;23(1):75-85.

319. Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids. Sun J, Xiao J, Sun R, Tang X, Liang C, Lin H, et

al. Emerging infectious diseases. 2020;26(8).

320. Potential factors influencing repeated SARS outbreaks in China. Sun Z, Thilakavathy K, Kumar SS, He G,

Liu SV. International Journal of Environmental Research and Public Health. 2020;17(5).

321. ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens. Suo T, Liu X, Feng J,

Guo M, Hu W, Guo D, et al. Emerging microbes & infections. 2020:1-30.

http://dx.doi.org/10.1080/22221751.2020.1772678.

322. Rhinologic Procedures in the Era of COVID-19: Health-care Provider Protection Protocol. Taha MA, Hall

CA, Rathbone RF, Corsten LA, Bowie CR, Waguespack PJ, et al. American journal of rhinology & allergy.

2020:1945892420927178. http://dx.doi.org/10.1177/1945892420927178.

323. A special case of COVID-19 with long duration of viral shedding for 49 days. Tan L, Kang X, Zhang B,

Zheng S, Liu B, Yu T, et al. medRxiv. 2020:2020.03.22.20040071.

324. Clinical features of children with SARS-CoV-2 infection: an analysis of 13 cases from Changsha, China.

Tan X, Huang J, Zhao F, Zhou Y, Li JQ, Wang XY. Zhongguo dang dai er ke za zhi = Chinese journal of contemporary

pediatrics. 2020;22(4):294-8.

325. Epidemiologic and clinical characteristics of 10 children with coronavirus disease 2019 in Changsha,

China. Tan YP, Tan BY, Pan J, Wu J, Zeng SZ, Wei HY. Journal of Clinical Virology. 2020;127.

326. Prevention and control strategies for emergency, limited-term, and elective operations in pediatric

surgery during the epidemic period of COVID-19. Tang D, Tou J, Wang J, Chen Q, Wang W, Huang J, et al. World

Journal of Pediatric Surgery. 2020;3(1).

327. Coronavirus disease 2019 (COVID-19): two case reports from a family cluster. Tang L, Ye Z, Huang Z,

Zeng X, Wang T, Xu R, et al. Annals of palliative medicine. 2020.

328. Positive RT-PCR tests among discharged COVID-19 patients in Shenzhen, China. Tang X, Zhao S, He D,

Yang L, Wang MH, Li Y, et al. Infection Control and Hospital Epidemiology. 2020:1-7.

329. Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a

retrospective case series. Thibodeaux K, Speyrer M, Raza A, Yaakov R, Serena TE. Journal of wound care.

2020;29:S4-s8. http://dx.doi.org/10.12968/jowc.2020.29.Sup5a.S4.

330. [Coronavirus disease 2019 (COVID-19): update for anesthesiologists and intensivists March 2020].

Thomas-Rüddel D, Winning J, Dickmann P, Ouart D, Kortgen A, Janssens U, et al. Der Anaesthesist. 2020;69(4):225-35.

http://dx.doi.org/10.1007/s00101-020-00758-x.

331. Characteristics of COVID-19 infection in Beijing. Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Z, et al.

Journal of Infection. 2020;80(4):401-6.

332. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Tian Y,

Rong L, Nian W, He Y. Alimentary Pharmacology and Therapeutics. 2020;51(9):843-51.

333. Consistent detection of 2019 novel coronavirus in saliva. To KKW, Tsang OTY, Chik-Yan Yip C, Chan KH,

Wu TC, Chan JMC, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of

America. 2020.

334. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody

responses during infection by SARS-CoV-2: an observational cohort study. To KKW, Tsang OTY, Leung WS, Tam

AR, Wu TC, Lung DC, et al. The Lancet Infectious Diseases. 2020;20(5):565-74.

335. Managing Cutaneous Immune-Mediated Diseases During the COVID-19 Pandemic. Torres T, Puig L.

American Journal of Clinical Dermatology. 2020.

336. The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan,

Lombardy Region. Trapani D, Marra A, Curigliano G. European Journal of Cancer. 2020;132:199-206.

337. Neonatal Resuscitation Where the Mother Has a Suspected or Confirmed Novel Coronavirus

(SARS-CoV-2) Infection: Suggestion for a Pragmatic Action Plan. Trevisanuto D, Moschino L, Doglioni N, Roehr

CC, Gervasi MT, Baraldi E. Neonatology. 2020.

338. Mathematical modelling of COVID-19 transmission and mitigation strategies in the population of

Ontario, Canada. Tuite AR, Fisman DN, Greer AL. CMAJ : Canadian Medical Association journal = journal de

l'Association medicale canadienne. 2020;192(19):E497-E505.

339. CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell

Engagement. Ulrich H, Pillat MM. Stem Cell Reviews and Reports. 2020.

340. In vitro diagnostic assays for COVID-19: Recent advances and emerging trends. Vashist SK. Diagnostics.

2020;10(4).

341. Transmission risk of SARS-CoV-2 to healthcare workers – observational results of a primary care

hospital contact tracing. Vera C, Heidi LS, Jan PR, Armin D, Lukas F, Tobias H, et al. Swiss Medical Weekly.

2020;150(19).

342. Anosmia and Dysgeusia in the Absence of Other Respiratory Diseases: Should COVID-19 Infection Be

Considered? Villalba NL, Maouche Y, Ortiz MBA, Sosa ZC, Chahbazian JB, Syrovatkova A, et al. European journal of

case reports in internal medicine. 2020;7(4):001641. http://dx.doi.org/10.12890/2020_001641. eCollection 2020.

343. Focal status epilepticus as unique clinical feature of COVID-19: A case report. Vollono C, Rollo E,

Romozzi M, Frisullo G, Servidei S, Borghetti A, et al. Seizure. 2020;78:109-12.

344. Lower respiratory tract infection in the community: associations between viral aetiology and illness

course. Vos LM, Bruyndonckx R, Zuithoff NPA, Little P, Oosterheert JJ, Broekhuizen BDL, et al. Clinical Microbiology

and Infection. 2020.

345. Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19.

Wacharapluesadee S, Kaewpom T, Ampoot W, Ghai S, Khamhang W, Worachotsueptrakun K, et al. Journal of medical

virology. 2020.

346. Evidence from two cases of asymptomatic infection with SARS-CoV-2: Are 14 days of isolation

sufficient? Wan R, Mao ZQ, He LY, Hu YC, Wei C. International Journal of Infectious Diseases. 2020;95:174-5.

347. Long-term Coexistence of SARS-CoV-2 with Antibody Response in COVID-19 Patients. Wang B, Wang

L, Kong X, Geng J, Xiao D, Ma C, et al. Journal of medical virology. 2020.

348. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia

in Wuhan, China. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. JAMA - Journal of the American Medical

Association. 2020;323(11):1061-9.

349. Rehospitalization of a Recovered Coronavirus Disease 19 (COVID-19) Child With Positive Nucleic Acid

Detection. Wang H, Li Y, Wang F, Du H, Lu X. The Pediatric infectious disease journal. 2020;39(6):e69-e70.

350. SARS-CoV-2 RNA detection of hospital isolation wards hygiene monitoring during the Coronavirus

Disease 2019 outbreak in a Chinese hospital. Wang J, Feng H, Zhang S, Ni Z, Ni L, Chen Y, et al. International

Journal of Infectious Diseases. 2020;94:103-6.

351. Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses. Wang N, Shang J, Jiang S, Du L.

Frontiers in Microbiology. 2020;11.

352. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a

Fangcang Hospital. Wang X, Fang J, Zhu Y, Chen L, Ding F, Zhou R, et al. Clinical microbiology and infection : the

official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2020.

http://dx.doi.org/10.1016/j.cmi.2020.03.032.

353. Nosocomial Outbreak of 2019 Novel Coronavirus Pneumonia in Wuhan, China. Wang X, Zhou Q, He Y,

Liu L, Ma X, Wei X, et al. The European respiratory journal. 2020.

354. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with

COVID-19. Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, et al. Journal of hepatology. 2020.

http://dx.doi.org/10.1016/j.jhep.2020.05.002.

355. Increased Pathogenicity and Virulence of Virus in Middle East Respiratory Syndrome Coronavirus

Clade B in Vitro and in Vivo. Wang Y, Sun J, Li X, Zhu A, Guan W, Sun DQ, et al. J Virol. 2020.

http://dx.doi.org/10.1128/JVI.00861-20.

356. Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan,

China. Wang Y, Tong J, Qin Y, Xie T, Li J, Li J, et al. Clin Infect Dis. 2020. http://dx.doi.org/10.1093/cid/ciaa629.

357. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe

COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial. Wang

Y, Zhou F, Zhang D, Zhao J, Du R, Hu Y, et al. Trials. 2020;21(1):422. http://dx.doi.org/10.1186/s13063-020-04352-9.

358. scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for

SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells. Wang Z, Xu X. Cells. 2020;9(4).

http://dx.doi.org/10.3390/cells9040920.

359. Minimizing intra-hospital transmission of COVID-19: the role of social distancing. Wee LE, Conceicao

EP, Sim XYJ, Aung MK, Tan KY, Wong HM, et al. Journal of Hospital Infection. 2020;105(2):113-5.

360. Implementation of Clinical Diagnostic Criteria and Universal Symptom Survey Contributed to Lower

Magnitude and Faster Resolution of the COVID-19 Epidemic in Wuhan. Wei Y, Wei L, Jiang Y, Shen S, Zhao Y, Hao

Y, et al. Engineering (Beijing, China). 2020. http://dx.doi.org/10.1016/j.eng.2020.04.008.

361. Clinical course and mortality risk of severe COVID-19. Weiss P, Murdoch DR. The Lancet.

2020;395(10229):1014-5.

362. Impact of the COVID-19 Pandemic on the Management of Head and Neck Malignancies. Werner MT,

Carey RM, Albergotti WG, Lukens JN, Brody RM. Otolaryngology--head and neck surgery : official journal of American

Academy of Otolaryngology-Head and Neck Surgery. 2020:194599820921413.

http://dx.doi.org/10.1177/0194599820921413.

363. Isolation, quarantine, social distancing and community containment: Pivotal role for old-style public

health measures in the novel coronavirus (2019-nCoV) outbreak. Wilder-Smith A, Freedman DO. Journal of Travel

Medicine. 2020;27(2).

364. Virological assessment of hospitalized patients with COVID-2019. Wölfel R, Corman VM, Guggemos W,

Seilmaier M, Zange S, Müller MA, et al. Nature. 2020.

365. Facemask shortage and the novel coronavirus disease (COVID-19) outbreak: Reflections on public

health measures. Wu HL, Huang J, Zhang CJP, He Z, Ming WK. EClinicalMedicine. 2020;21.

366. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Wu Y, Guo C, Tang L, Hong Z, Zhou J,

Dong X, et al. The Lancet Gastroenterology and Hepatology. 2020;5(5):434-5.

367. COVID-19 - what should anaethesiologists and intensivists know about it? Wujtewicz M,

Dylczyk-Sommer A, Aszkiełowicz A, Zdanowski S, Piwowarczyk S, Owczuk R. Anaesthesiology intensive therapy.

2020;52(1):34-41.

368. Epidemiological and clinical characteristics of discharged patients infected with SARS-CoV-2 on the

Qinghai plateau. Xi A, Zhuo M, Dai J, Ding Y, Ma X, Ma X, et al. J Med Virol. 2020.

http://dx.doi.org/10.1002/jmv.26032.

369. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients. Xiao AT, Tong YX,

Zhang S. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.

370. Prolonged viral shedding in feces of pediatric patients with coronavirus disease 2019. Xing YH, Ni W,

Wu Q, Li WJ, Li GJ, Wang WD, et al. Journal of Microbiology, Immunology and Infection. 2020.

371. Clinical Characteristics and Outcomes of 421 Patients with COVID-19 Treated in a Mobile Cabin

Hospital. Xiong Z, Xin C, Yan MX, Cai Y, Zhou K, Xie C, et al. Chest. 2020.

http://dx.doi.org/10.1016/j.chest.2020.05.515.

372. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in

Wuhan, China. Xu B, Fan CY, Wang AL, Zou YL, Yu YH, He C, et al. Journal of Infection. 2020.

373. Management of corona virus disease-19 (COVID-19): the Zhejiang experience. Xu K, Cai H, Shen Y, Ni Q,

Chen Y, Hu S, et al. Zhejiang da xue xue bao Yi xue ban = Journal of Zhejiang University Medical sciences.

2020;49(1):0.

374. Factors associated with prolonged viral RNA shedding in patients with COVID-19. Xu K, Chen Y, Yuan J,

Yi P, Ding C, Wu W, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of

America. 2020.

375. Clinical features and dynamics of viral load in imported and non-imported patients with COVID-19. Xu

T, Chen C, Zhu Z, Cui M, Chen C, Dai H, et al. International Journal of Infectious Diseases. 2020;94:68-71.

376. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral

shedding. Xu Y, Li X, Zhu B, Liang H, Fang C, Gong Y, et al. Nature Medicine. 2020;26(4):502-5.

377. SARS2-CoV-2 and Stroke in a New York Healthcare System. Yaghi S, Ishida K, Torres J, Mac Grory B, Raz

E, Humbert K, et al. Stroke. 2020:Strokeaha120030335. http://dx.doi.org/10.1161/STROKEAHA.120.030335.

378. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E

replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells. Yamaya

M, Nishimura H, Deng X, Sugawara M, Watanabe O, Nomura K, et al. Respiratory Investigation. 2020;58(3):155-68.

379. Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection. Yang JR,

Deng DT, Wu N, Yang B, Li HJ, Pan XB. Journal of medical virology. 2020.

380. Patients with respiratory symptoms are at greater risk of COVID-19 transmission. Yang R, Gui X, Xiong

Y. Respiratory Medicine. 2020;165.

381. Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab. Yekedüz E,

Dursun B, Aydın GÇ, Yazgan SC, Öztürk HH, Azap A, et al. Journal of oncology pharmacy practice : official publication

of the International Society of Oncology Pharmacy Practitioners. 2020:1078155220924084.

382. Vytr hypothesis for the prophylactic and therapeutic efficacy of GS-5734 treatment in humans with

COVID-19. Yethindra V, Dzhangazieva A, Kurzhunbaeva Z, Tagaev T, Nazami F. International Journal of Research in

Pharmaceutical Sciences. 2020;11:19-22.

383. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity

of COVID-19 patients. Yongchen Z, Shen H, Wang X, Shi X, Li Y, Yan J, et al. Emerging microbes & infections.

2020;9(1):833-6.

384. Clinical Significance of a High SARS-CoV-2 Viral Load in the Saliva. Yoon JG, Yoon J, Song JY, Yoon SY,

Lim CS, Seong H, et al. J Korean Med Sci. 2020;35(20):e195. http://dx.doi.org/10.3346/jkms.2020.35.e195.

385. Epidemiologic Features and Clinical Course of Patients Infected with SARS-CoV-2 in Singapore. Young

BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, Loh J, et al. JAMA - Journal of the American Medical Association.

2020;323(15):1488-94.

386. A comprehensive Chinese experience against SARS-CoV-2 in ophthalmology. Yu AY, Tu R, Shao X, Pan

A, Zhou K, Huang J. Eye and vision (London, England). 2020;7:19. http://dx.doi.org/10.1186/s40662-020-00187-2.

eCollection 2020.

387. The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected

discharged patients. Yuan J, Zou R, Zeng L, Kou S, Lan J, Li X, et al. Inflammation Research. 2020;69(6):599-606.

388. The application of Temporary Ark Hospitals in controlling COVID-19 spread: the experiences of one

Temporary Ark Hospital, Wuhan, China. Yuan Y, Qiu T, Wang T, Zhou J, Ma Y, Liu X, et al. Journal of medical

virology. 2020.

389. SARS-CoV-2 and COVID-19: The most important research questions. Yuen KS, Ye ZW, Fung SY, Chan CP,

Jin DY. Cell and Bioscience. 2020;10(1).

390. Why the SARS-Cov-2 has prolonged spreading time in children? Yurttutan S, İpek S, Güllü UU. Pediatric

Pulmonology. 2020.

391. Laboratory diagnostics within a modular hospital at the time of Coronavirus disease 2019 (COVID-19)

in Wuhan. Yusong L, Duanliang P, Jia Y, Dunyan C, Hongbing J, Siyuan Y, et al. Clinical Chemistry and Laboratory

Medicine. 2020.

392. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Zaigham M,

Andersson O. Acta Obstetricia et Gynecologica Scandinavica. 2020.

393. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Zang R,

Gomez Castro MF, McCune BT, Zeng Q, Rothlauf PW, Sonnek NM, et al. Science immunology. 2020;5(47).

394. Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19). Zha L, Li S, Pan L,

Tefsen B, Li Y, French N, et al. Medical Journal of Australia. 2020;212(9):416-20.

395. Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019

(COVID-19). Zhang L, Yu J, Zhou Y, Shen M, Sun L. American Journal of Chinese Medicine. 2020.

396. Viral Shedding Prolongation in a Kidney Transplant Patient with COVID-19 Pneumonia. Zhang M,

Zhang J, Shi H, Liu B, Zeng F. American journal of transplantation : official journal of the American Society of

Transplantation and the American Society of Transplant Surgeons. 2020.

397. Experience summary of a COVID-19 designated community hospital and its operation model. Zhang

Q, Cheng S, Cheng Q. Panminerva medica. 2020.

398. Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19

pneumonia. Zhang T, Cui X, Zhao X, Wang J, Zheng J, Zheng G, et al. Journal of Medical Virology. 2020.

399. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple

shedding routes. Zhang W, Du RH, Li B, Zheng XS, Yang XL, Hu B, et al. Emerging Microbes and Infections.

2020;9(1):386-9.

400. Prolonged Viral RNA Shedding Duration in COVID-19. Zhang WY, Yu LQ, Huang JA, Zeng DX. American

journal of therapeutics. 2020.

401. The evidence of SARS-CoV-2 infection on ocular surface. Zhang X, Chen X, Chen L, Deng C, Zou X, Liu W,

et al. Ocular Surface. 2020;18(3):360-2.

402. Novel Coronavirus Infection in Newborn Babies Under 28 Days in China. Zhang ZJ, Yu XJ, Fu T, Liu Y,

Jiang Y, Yang BX, et al. The European respiratory journal. 2020.

403. The Time Sequences of Oral and Fecal Viral Shedding of Coronavirus Disease 2019 (COVID-19)

Patients. Zhao F, Yang Y, Wang Z, Li L, Liu L, Liu Y. Gastroenterology. 2020.

404. Early virus clearance and delayed antibody response in a case of COVID-19 with a history of

co-infection with HIV-1 and HCV. Zhao J, Liao X, Wang H, Wei L, Xing M, Liu L, et al. Clinical infectious diseases : an

official publication of the Infectious Diseases Society of America. 2020.

405. Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection.

Zhao R, Li M, Song H, Chen J, Ren W, Feng Y, et al. Clinical infectious diseases : an official publication of the Infectious

Diseases Society of America. 2020.

406. Modeling the epidemic dynamics and control of COVID-19 outbreak in China. Zhao S, Chen H.

Quantitative biology (Beijing, China). 2020:1-9. http://dx.doi.org/10.1007/s40484-020-0199-0.

407. Risk-adapted Treatment Strategy For COVID-19 Patients. Zheng C, Wang J, Guo H, Lu Z, Ma Y, Zhu Y, et

al. International Journal of Infectious Diseases. 2020;94:74-7.

408. Early Prediction of the 2019 Novel Coronavirus Outbreak in the Mainland China Based on Simple

Mathematical Model. Zhong L, Mu L, Li J, Wang J, Yin Z, Liu D. IEEE access : practical innovations, open solutions.

2020;8:51761-9. http://dx.doi.org/10.1109/ACCESS.2020.2979599. eCollection 2020.

409. The duration of viral shedding of discharged patients with severe COVID-19. Zhou B, She J, Wang Y, Ma

X. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020.

410. SARS-CoV-2 shedding and infectivity – Authors' reply. Zhou F, Fan G, Liu Z, Cao B. The Lancet.

2020;395(10233):1340.

411. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a

retrospective cohort study. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. The Lancet. 2020;395(10229):1054-62.

412. Infection of bat and human intestinal organoids by SARS-CoV-2. Zhou J, Li C, Liu X, Chiu MC, Zhao X,

Wang D, et al. Nature Medicine. 2020.

413. Viral dynamics in asymptomatic patients with COVID-19. Zhou R, Li F, Chen F, Liu H, Zheng J, Lei C, et al.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious

Diseases. 2020;96:288-90. http://dx.doi.org/10.1016/j.ijid.2020.05.030.

414. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Zhu H, Wang L, Fang C,

Peng S, Zhang L, Chang G, et al. Translational pediatrics. 2020;9(1):51-60.

415. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary

of 10 Confirmed Cases in Wuhan, China. Zhu L, Gong N, Liu B, Lu X, Chen D, Chen S, et al. European Urology. 2020.

416. [Evaluation of the emergency response strategies and measures on the epidemic of COVID-19 in

Shenzhen, China]. Zou X, Wu YS, Liu XJ, Huang SL, He JF, Zhao J, et al. Zhonghua liu xing bing xue za zhi = Zhonghua

liuxingbingxue zazhi. 2020;41:E056. http://dx.doi.org/10.3760/cma.j.cn112338-20200316-00360.

417. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Zuo T, Zhang

F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Gastroenterology. 2020. http://dx.doi.org/10.1053/j.gastro.2020.05.048.